Achieve Life Sciences (ACHV) Misses Q3 EPS by 4c

Achieve Life Sciences (NASDAQ: ACHV) reported Q3 EPS of ($0.28), $0.04 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Canaccord Reiterates Buy Rating on Achieve Life Sciences (ACHV)
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance